Recurring brain tumor growth is halted with new drug - EurekAlert

5/9/2022 12:00:00 AM3 yearsago
When a non-metastatic brain tumor — a meningioma — recurs after surgery and radiation treatment, a patient is out of options. No drugs are approved for these aggressive tumors, which occur in up to 20% of cases and can lead to patient disability or even death…
- Currently no treatment for recurring non-metastatic brain tumor
- About 20% to 30% of meningiomas recur and can lead to patient disability or death
- Study identifies which patien… [+5121 chars] full article...